CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishAlpha-enolase (ENO1) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and mediates the activation of plasmin and extracellular matrix degradation. In tumor cells, ENO1 is up-regulated and supports the Warburg effect; it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. ENO1 overexpression and post-translational modifications could be of diagnostic and prognostic value in many cancer types. Information on the biochemical, proteomics and immunological characterization of ENO1, and particularly its ability to trigger a strong specific humoral and cellular immune response, make this ubiquitous protein an interesting tumor target; DNA vaccination with ENO1 in preclinical models efficiently delays the development of very aggressive tumors such as pancreatic cancer. This review aims to analyze the main stages by which the tumor associated antigen (TAA) ENO1 has become a promising target that opens potential avenues for cancer immunotherapy.
| Titolo: | Alpha-Enolase (ENO1), a potential target in novel immunotherapies | |
| Autori Riconosciuti: | ||
| Autori: | Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco | |
| Data di pubblicazione: | 2017 | |
| Abstract: | Alpha-enolase (ENO1) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and mediates the activation of plasmin and extracellular matrix degradation. In tumor cells, ENO1 is up-regulated and supports the Warburg effect; it is expressed at the cell surface, where it promotes cancer invasion, and is subjected to a specific array of post-translational modifications, namely acetylation, methylation and phosphorylation. ENO1 overexpression and post-translational modifications could be of diagnostic and prognostic value in many cancer types. Information on the biochemical, proteomics and immunological characterization of ENO1, and particularly its ability to trigger a strong specific humoral and cellular immune response, make this ubiquitous protein an interesting tumor target; DNA vaccination with ENO1 in preclinical models efficiently delays the development of very aggressive tumors such as pancreatic cancer. This review aims to analyze the main stages by which the tumor associated antigen (TAA) ENO1 has become a promising target that opens potential avenues for cancer immunotherapy. | |
| Volume: | 22 | |
| Fascicolo: | 5 | |
| Pagina iniziale: | 944 | |
| Pagina finale: | 959 | |
| Digital Object Identifier (DOI): | 10.2741/4526 | |
| URL: | https://www.bioscience.org/fbs/getfile.php?FileName=/2017/v22/af/4526/4526.pdf | |
| Parole Chiave: | Alpha-enolase; ENO1; Cancer; Humoral Response; Glycolysis; Invasion; Immunotherapy; Pancreatic Cancer; Plasminogen Receptor; T cell response; Vaccination; TAAs; Metastasis; Review | |
| Rivista: | FRONTIERS IN BIOSCIENCE | |
| Appare nelle tipologie: | 03B-Review in Rivista / Rassegna della Lett. in Riv. / Nota Critica |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Cappello_front biosci_2017.pdf | post-print | POSTPRINT (VERSIONE FINALE DELL’AUTORE) | Open Access Visualizza/Apri | |
| Cappello P et la, Frontiers 2017.pdf | Cappello P et al, Front biasci 2017 | PDF EDITORIALE | Utenti riconosciuti Richiedi una copia |
Copyright © 2021